Displaying items by tag: department of medicine

The risk factors for stroke in the South also may be responsible for cognitive decline.

By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

Page 36 of 36